TCT-841 ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials

Salvatore Cassese; Giuseppe De Luca; Flavio Ribichini; C Cernigliaro; Francesco Versaci; Igino Proietti; Goran Stanković; Siniša Stojković; Fabrizio Tomai; Corrado Vassanelli; David Antoniucci; Patrick W. Serruys; Adnan Kastrati; Alfredo Santana

doi:10.1016/j.jacc.2013.08.1595

Related publications

Article2014

ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: A patient-level meta-analysis of randomized trials

Salvatore Cassese, Giuseppe De Luca, Flavio Ribichini, C Cernigliaro, Mara Sansa, Francesco Versaci, Igino Proietti, Goran Stanković, Siniša Stojković, Carlos Fernández‐Pereira, Fabrizio Tomai, Corrado Vassanelli, David Antoniucci, Patrick W. Serruys, Adnan Kastrati, Alfredo E. Rodríguez

Atherosclerosis

Article2013

ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials

Salvatore Cassese, Giuseppe De Luca, Flavio Ribichini, C Cernigliaro, Francesco Versaci, Goran Stanković, David Antoniucci, Patrick W. Serruys, Adnan Kastrati, Aryelly Rodríguez

European Heart Journal

Article2018

TCT-584 Long-Term Impact of Improving Drug-Eluting Stent Technology in Patients Undergoing Multilesion Intervention: A Patient-Level Analysis of 19 Randomized Trials

Paul Guedeney, Roxana Mehran, Bimmer E. Claessen, Mengdan Liu, Sabato Sorrentino, Serdar Farhan, Martin B. Leon, Patrick W. Serruys, Pieter C. Smits, Clemens von Birgelen, Ori Ben‐Yehuda, Mahesh V. Madhavan, Björn Redfors, Gregg W. Stone

Journal of the American College of Cardiology

Article2018

TCT-692 Impact of Drug-Eluting Stent Generation in Elderly Patients Undergoing PCI: Five-Year Follow-up From a Patient-Level Analysis of 19 Randomized Trials

Paul Guedeney, Roxana Mehran, Bimmer E. Claessen, Sabato Sorrentino, Mengdan Liu, Serdar Farhan, Martin B. Leon, Patrick W. Serruys, Pieter C. Smits, Clemens von Birgelen, Ori Ben‐Yehuda, Mahesh V. Madhavan, Björn Redfors, Gregg W. Stone

Journal of the American College of Cardiology

Article2019

TCT-844 Very Late (>1 Year) Stent-Related Adverse Cardiovascular Events: Individual Patient Data and Network Meta-Analyses From 19 Randomized Clinical Trials

Mahesh V. Madhavan, Ajay J. Kirtane, Björn Redfors, John Burton, Ori Ben‐Yehuda, Tullio Palmerini, Umberto Benedetto, Giuseppe Biondi‐Zoccai, Pieter C. Smits, Clemens von Birgelen, Roxana Mehran, Thomas McAndrew, Patrick W. Serruys, Martin B. Leon, Stuart J. Pocock, Gregg W. Stone

Journal of the American College of Cardiology

TCT-841 ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials

Abstract

Discussion(0)

Related publications

ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: A patient-level meta-analysis of randomized trials

ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials

TCT-584 Long-Term Impact of Improving Drug-Eluting Stent Technology in Patients Undergoing Multilesion Intervention: A Patient-Level Analysis of 19 Randomized Trials

TCT-692 Impact of Drug-Eluting Stent Generation in Elderly Patients Undergoing PCI: Five-Year Follow-up From a Patient-Level Analysis of 19 Randomized Trials

TCT-844 Very Late (>1 Year) Stent-Related Adverse Cardiovascular Events: Individual Patient Data and Network Meta-Analyses From 19 Randomized Clinical Trials

TCT-841 ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials

Abstract

Discussion(0)

Related publications

ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: A patient-level meta-analysis of randomized trials

ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials

TCT-584 Long-Term Impact of Improving Drug-Eluting Stent Technology in Patients Undergoing Multilesion Intervention: A Patient-Level Analysis of 19 Randomized Trials

TCT-692 Impact of Drug-Eluting Stent Generation in Elderly Patients Undergoing PCI: Five-Year Follow-up From a Patient-Level Analysis of 19 Randomized Trials

TCT-844 Very Late (&gt;1 Year) Stent-Related Adverse Cardiovascular Events: Individual Patient Data and Network Meta-Analyses From 19 Randomized Clinical Trials

TCT-844 Very Late (>1 Year) Stent-Related Adverse Cardiovascular Events: Individual Patient Data and Network Meta-Analyses From 19 Randomized Clinical Trials